ASCOD Algorithm for Ischemic Stroke
Why Use
May aid in comprehensive evaluation of diagnostic work-up and findings to capture all existing underlying disease mechanisms in ischemic stroke patients, thus potentially guiding risk factor management for secondary prevention. Compared with TOAST, reduces proportion of strokes labelled “of undetermined etiology” despite extensive work-up ( Radu 2017 ).
When to Use
Use in patients for comprehensive evaluation of all potential underlying causes of ischemic stroke, which may aid in those of unclear or overlapping etiology.
Formula
Pearls / Pitfalls
ASCOD phenotyping of ischemic stroke seeks to assign a degree of likelihood of causal relationship for every potential underlying disease mechanism, without weighing towards most likely cause. Compared to other ischemic stroke subtype classification systems: Classifies subtypes into large-vessel atherosclerosis, small-vessel disease (lacunar), cardioembolic, and other etiologies including dissection, like TOAST (Trial of Org 10172 in Acute Stroke Treatment). Does not assign a “cryptogenic” or “undetermined” category, which creators propose may reduce confusion amongst both clinicians and patients. Captures overlap between multiple underlying ischemic stroke mechanisms. Evaluates thoroughness and appropriateness of diagnostic evidence. Relies on presence or absence of an abnormality, and does not directly compare competing ischemic stroke etiologies.
Management
Management is dependent on identified mechanism(s), and may include anticoagulation, anti-thrombotics, high-intensity anti-lipids, blood pressure and glycemic control, carotid endarterectomy, and/or atrial septal defect repair.
Critical Actions
ASCOD addresses underlying ischemic stroke mechanisms, not all aspects of post-stroke care, which can include rehabilitation, physical therapy, occupational therapy, and speech language therapy.
Advice
Incomplete minimum work-up may prompt further diagnostic testing listed in scoring criteria. Potential causal disease mechanisms should be treated according to current evidence-based guidelines for secondary stroke prevention. Multiple potentially causal disease mechanisms should all be considered for treatment.